Hypernatraemia (serum sodium concentration of 150 mmol/L or more) is most likely to occur in a child suffering from diarrhoea with inadequate intake of fluid, repeated vomiting, intake of concentrated ORS or undiluted cow's milk. . Most children with hypernatraemia are dehydrated, but do not show typical signs and symptoms of dehydration. 3 Patients with hypernatraemia are usually irritable, restless, weak and lethargic. Alert patients are very thirsty, they may have fever. Seizure & coma are possible squeals of brain hemorrhage. 4 However, little is known about its magnitude and associated morbidity and mortality, particularly from developing countries. 5 Two different studies from ICDDR,B showed the incidence of hypernatraemia to be 6.4% and 5.1%, respectively. 6 No such data is available from other Specialized Paediatric Hospitals in the country. WHO estimates that there are >700 million episodes of diarrhoea annually in children <5yrs of age in developing countries. While global mortality may be declining the overall incidence of diarrhoea remains unchanged at least 3.2 episodes/child/ year. The decline in diarrhoeal mortality, despite the lack of significant changes in incidence, is the result of improved case management of diarrhea, as well as improved nutrition of infants and children. These interventions have included widespread home and hospital based oral rehydration therapy, as well as improved nutritional management of children with diarrhoea .Persistently high rates of diarrhoea among young children despite intensive efforts at control are of particular concern. 7 The objective of the study is to find out the frequency of hypernatraemia, its clinical presentation and the immediate outcome in two different specialist paediatric hospital settings.
Methodology:
This prospective comparative study was conducted in inpatient departments of Dhaka Shishu Hospital, Sher-e-Bangla Nagar, Shyamoli and ICH & Shishu Sasthya Foundation Hospital, Mirpur-2, Dhaka over a period of 6 months from 10 th August,2011to10th February 2012. Total 107 children aged 2 months to 5 years admitted for acute watery diarrhoea were selected consecutively for the study. Written consents were obtained from the accompanying persons. They were then assessed for clinical conditions following the inpatient pediatric protocol at the selected hospital. Structured questionnaire including clinical and laboratory data were completed for all cases. Blood samples were collected just after clinical examination and the treatment was started according to standard protocol of the hospital. All the patients were then followed up for 72 hours to see the treatment outcome. Investigation results were obtained within 4 hours of admission and once there was hypernatraemia, the serum electrolytes were repeated at 24 and 72 hours. The outcomes were cautiously recorded and later analyzed. For data analysis, SPSS statistical package was used and analyzed using Chi-square (χ 2 ) Test, One-Way ANOVA Test and Repeated Measure ANOVA statistics. Children who had persistent diarrhoea, acute diarrhoea with associated problems, blood mixed stool, parents of children unwilling to give consent were excluded from the study.
Results:
A total of 107 patients age ranging from 2 months to 5 years were enrolled for the study, of which 12(11.2%) were found hypernatraemic. Among them, 4 patients had mild (Na + : <160 mmol/L); 5 had moderate ( Na + : 160-170 mmol/L) and 3 had severe (Na + : >170 mmol/ (Table II) . The proportion of patients with intact consciousness at baseline and after 24 hours was lower in the severe hypernatraemic patients than that in the mild and moderate groups. However, the percentage of intact consciousness after 72 hours was less in moderate hypernatraemic patients compared to other counterparts. Fifty percent (50%) of patients in mild and 60% moderate hypernatraemic patients had normal motor function, while all severe hypernatraemic patients had abnormal motor functions. The improvement of motor function reached to 100% in mild and moderate hypernatraemic patients within 3 days of treatment, but not in the severe group. In all of them motor functions took more than 3 days to return to normal. Intact sensory function was available in mild, moderate and severe hypernatraemic patients at baseline. Twenty percent of moderate hypernatraemic patients had paresthesia at baseline and it continued up to 72 hours, while 33.3% of severe hypernatraemic patients developed paresthesia after 24 hours and returned to normal at 72 hours. All of the patients had signs of severe dehydration at baseline in all three groups. After 24 hours, 40% of moderate and 33.3% of severe hypernatraemic patients still had some signs of dehydration (p = 0.360) (Table III) . # Repeated measure ANOVA statistics was employed to analyse the data and 'p' refers to overall differences between groups * Data were analyzed using Chi-square (χ χ χ χ χ 2 ) Test.
Three (75%) mild hypernatraemic, 3 (60%) moderate and 1 (33.3%) severe hypernatraemic patients received oral rehydration solutions (ORS). Two (50%) mild, 4 (60%) moderate and 1 (33.3%) hypernatraemic patient had a history of medication before hospitalization. Every one of the hypernatraemic patients was given IV fluid immediately to replace fluid deficit. Two (40%) out of 5 moderate and 3 (100%) of severe hypernatraemic patients needed dialysis for acute disease (p = 0.029) ( Table IV) . All of the mild and moderate and 1 (33.3%) severe hypernatraemic patients improved, while 2 (66.7%) of 3 severe hypernatraemic patients died during treatment (Figure 1 ). hospitalized patient, which was approximately 11.2%. Anderson et all [8] [9] found a prevalence of 10.4% when defining hypertrenaemia as serum sodium concentration >150 mEq/L; our results using this definition is similar. Findings of current study showed mean age and weight of severe hypernatraemic patients was higher than those of mild and moderate and male was higher in moderate compared to those in mild and severe hypernatremic patients. All (100%) of mild hypernatraemic patients were suffering from acute diarrhea for three days. In case of moderate hypernatraemia, 20% patients were suffering from diarrhoea for two days, 60% for three days and another 20% for four days. One-third (33.3%) of severe hypernatraemic patients were suffering from diarrhoea for three days and rest 66.7% for four days. Three (75%) mild hypernatraemic patients exhibited vomiting (66.7% for one day and 33.3% for two days). All (100%) moderate hypernatraemic patients had vomiting (20% for one day, 60% for two days and 20%> three days) and all (100%) severe hypernatraemic patients had vomiting for >3 days.
Table-IV Treatment history throughout observation period
The patients with other signs and symptoms like convulsion, irritability, seizures, increased in muscle tone were higher in severe hypernatraemic patients than mild and moderate patients. As has been stressed in these studies, Tierney et al 10 reported that 11 (10.7%) of 103 patients developed hypernatraemia during hospitalization. Patients who developed hypernatraemia during hospitalization were younger in case of mild hypernatraemia than moderate and severe patients (mean age ± SD, 1.9 ± 0.2 years compared with 2.6 ± 1.7 years and 3.7 ± 0.9 years; P < 0.01). Fifty-five percent of severe hypernatraemic patients had increased insensible water losses and 35% had convulsion, 76% high-pitched cry or wail. However, previous study conducted by Long et al 11 observed that vomiting and increased muscle tone varied widely among different grade of hypernatremic patients.
Consciousness at baseline was intact in all patients in mild and moderate hypernatraemic pt, but significantly worse in patients with severe hypernatraemia(66%) than with moderate and mild hypernatraemia. At 72 hours, consciousness improved in all patients. Surprisingly, however, it was still somehow altered in patients with moderate hypernatraemia, although it returned to almost normal in patients with mild and severe hypernatraemia. The reason for this discrepancy remained unclear. 
Discussion:
The present study highlights the prevalence of hypertrenaemia (serum Na + > 150mEq/L) in Abnormal motor function (hypo or hypertonic) was observed in all the patients with severe hypernatraemia, while the same was observed in 50% in mild and 40% in moderate hypernatraemic patients. Twenty percent of moderate hypernatraemic patients had complaint of paresthesia at baseline, and another 20% developed the same at 72 hours, while only 33.3% of severe hypernatraemic patients exhibited the same at 24 hours. On the other hand, none of the patients with mild hypernatraemia had any complaint of altered sensory function. Almost similar results of paresthesia was also reported by others. 12 Snyder & Merson, however, found that some residual weakness was still persisting in some patients even after 72 hours who had both motor and sensory function altered. They, therefore, emphasized that long time follow up would be essential in these patients. 13 Our study reveals that all the patients with mild and moderate and 1 (33.3%) of severe hypernatraemic patients improved after treatment. Two (66.7%) of 3 severe hypernatraemic children died during treatment. Alshayeb and associates 14 demonstrated that mean admission serum Na + level was 159 ± 3 mEq/L. Ninety percent of their patients received the recommended <0.5 mEq/L/hr serum Na + correction rate; however, hypernatremia was corrected only in 27% of patients after 72 hours of treatment. On third-day, patient mortality rate was 37%. The mortality rate in our study (66.7%) in severe hypernatraemia was almost similar with other studies (66%). [15] [16] The mortality we also observed is similar to that reported in other studies of hypernatremia. 7, 15, 17, 18, 19, 20 
Conclusion:
Hypernatraemia is not uncommon in our hospitalized population. There are important differences in the prognostic significance of hypernatraemia across clinical settings. Hypernatraemic dehydration remains an important, serious complication in this study and resulted high mortality in patients with severe hypernatraemia. Early identification, proper medical examination and management may be helpful for the solution of the problem and can provide the exact estimate of the burden.
